AAAAAA

   
Results: 1-8 |
Results: 8
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
Authors: Strizki, JM Xu, S Wagner, NE Wojcik, L Liu, J Hou, Y Endres, M Palani, A Shapiro, S Clader, JW Greenlee, WJ Tagat, JR McCombie, S Cox, K Fawzi, AB Chou, CC Pugliese-Sivo, C Davies, L Moreno, ME Ho, DD Trkola, A Stoddart, CA Moore, JP Reyes, GR Baroudy, BM
Citation: Jm. Strizki et al., SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo, P NAS US, 98(22), 2001, pp. 12718-12723
Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1 '-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4 '-methyl-1,4 '-bipiperidine N-oxide (SCH 351125):An orally bioavailable human CCR5 antagonist for the treatment of HIV infection
Authors: Palani, A Shapiro, S Clader, JW Greenlee, WJ Cox, K Strizki, J Endres, M Baroudy, BM
Citation: A. Palani et al., Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1 '-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4 '-methyl-1,4 '-bipiperidine N-oxide (SCH 351125):An orally bioavailable human CCR5 antagonist for the treatment of HIV infection, J MED CHEM, 44(21), 2001, pp. 3339-3342
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4-methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro-methyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist
Authors: Tagat, JR Steensma, RW McCombie, SW Nazareno, DV Lin, SI Neustadt, BR Cox, K Xu, S Wojcik, L Murray, MG Vantuno, N Baroudy, BM Strizki, JM
Citation: Jr. Tagat et al., Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4-methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro-methyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist, J MED CHEM, 44(21), 2001, pp. 3343-3346
Cross-genotypic interaction between hepatitis C virus NS3 protease domainsand NS4A cofactors
Authors: Wright-Minogue, J Yao, NH Zhang, RM Butkiewicz, NJ Baroudy, BM Lau, JYN Hong, Z
Citation: J. Wright-minogue et al., Cross-genotypic interaction between hepatitis C virus NS3 protease domainsand NS4A cofactors, J HEPATOL, 32(3), 2000, pp. 497-504
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3
Authors: Butkiewicz, N Yao, NH Wong, WD Wright-Minogue, J Ingravallo, P Zhang, RM Durkin, J Standring, DN Baroudy, BM Sangar, DV Lemon, SM Lau, JYN Hong, Z
Citation: N. Butkiewicz et al., Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3, J VIROLOGY, 74(9), 2000, pp. 4291-4301
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding
Authors: Jubin, R Vantuno, NE Kieft, JS Murray, MG Doudna, JA Lau, JYN Baroudy, BM
Citation: R. Jubin et al., Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding, J VIROLOGY, 74(22), 2000, pp. 10430-10437
Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees
Authors: Hong, Z Beaudet-Miller, M Lanford, RE Guerra, B Wright-Minogue, J Skelton, A Baroudy, BM Reyes, GR Lau, JYN
Citation: Z. Hong et al., Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees, VIROLOGY, 256(1), 1999, pp. 36-44
Characterization of soluble hepatitis C virus RNA-dependent RNA polymeraseexpressed in Escherichia coli
Authors: Ferrari, E Wright-Minogue, J Fang, JWS Baroudy, BM Lau, JYN Hong, Z
Citation: E. Ferrari et al., Characterization of soluble hepatitis C virus RNA-dependent RNA polymeraseexpressed in Escherichia coli, J VIROLOGY, 73(2), 1999, pp. 1649-1654
Risultati: 1-8 |